argenx NV ADR
Price & Volume
Stats
See more52W Range | $510.05-$872.91 |
Market Cap | $52.6B |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $3.6B |
Revenue Growth (YoY) | 95.5% |
Gross Profit (12 Mos) | $2B |
Diluted EPS | $23.42 |
News
See moreYahoo Finance • 6 days ago
Argenx Gains Health Canada Approval For Vyvgart SC As Monotherapy In CIDP
Yahoo Finance • 8 days ago
argenx SE (ARGX) Rose due to Increased Sales of its Vyvgart Medication
Yahoo Finance • 13 days ago
argenx SE beats top-line and bottom-line estimates; reaffirms FY25 outlook
Yahoo Finance • 13 days ago
argenx Reports Third Quarter 2025 Financial Results and Provides Business Update
About
CEO | Mr. Timothy Van Hauwermeiren EMBA, M.Sc. |
Address | Laarderhoogtweg 25, Amsterdam, Netherlands, 1101 EB |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,599 |
